ID
13106
Description
Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab; ODM derived from: https://clinicaltrials.gov/show/NCT00393107
Link
https://clinicaltrials.gov/show/NCT00393107
Keywords
Versions (1)
- 1/17/16 1/17/16 -
Uploaded on
January 17, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Follicular Lymphoma NCT00393107
Eligibility Follicular Lymphoma NCT00393107
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
hiv
Data type
boolean
Alias
- UMLS CUI [1]
- C0019682
Description
hepatitis b or c
Data type
boolean
Alias
- UMLS CUI [1]
- C0019163
- UMLS CUI [2]
- C0019196
Description
cns lymphoma
Data type
boolean
Alias
- UMLS CUI [1]
- C0280803
Description
comorbidity
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
pregnancy, lactation, contraception
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
- UMLS CUI [3]
- C0700589
Similar models
Eligibility Follicular Lymphoma NCT00393107
- StudyEvent: Eligibility
C0919553 (UMLS CUI [1,2])
C0054946 (UMLS CUI [1,3])
C1706867 (UMLS CUI [2])
C0555954 (UMLS CUI [3])
C3146298 (UMLS CUI [1,2])
C0019196 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])